Gen-Probe Inc.

Company Website

10210 Genetic Center Dr.
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Gen-Probe Inc.

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

Market Cap as of 06/26/2012

$3,721,706,055

Market Cap as of 01/04/2012

$2,675,503,000

Market Cap as of 06/20/2011

$3,261,492,000

Market Cap as of 01/06/2011

$2,832,204,000

Exchange and Ticker Symbol

Nasdaq: GPRO

Fields of Research

Development, manufacture and marketing of molecular diagnostic products and services that are used primarily to diagnose human diseases and screen donated human blood

Major Products

APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays;
APTIMA Trichomonas ASRs;
APTIMA HPV assay;
AccuProbe Group B Streptococcus (GBS) assay;
ProFlu+;
ProFAST+;
ProGastro Cd; and more

View all the companies in San Diego Publicly Traded Companies

Gen-Probe Inc.

Market Cap as of 6/12/2015

Exchange

NASDAQ GS

Ticker

GPRO

Executives

Henry Nordhoff (profile)

  • Chief Executive Officer
  • President

Carl Hull

  • Chairman
  • Chief Executive Officer
  • President

Similar Companies

Surgical and Medical Instrument Manufacturing339112
MEASURING AND CONTROLLING DEVICES, NOT ELSEWHERE CLASSIFIED3829
Surgical Appliance and Supplies Manufacturing339113
SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS3841
Research and Development in the Social Sciences and Humanities541720
NONCOMMERCIAL RESEARCH ORGANIZATIONS8733